Abingworth works alongside entrepreneurs to develop their ideas into products that have an impact on health. Within this market, the Company participates in a wide range of opportunities spanning therapeutics, medical devices, diagnostics, instrumentation, and software. Abingworth invests in seed stage projects, technology platforms, preclinical and clinical assets as well as approved and marketed products. Supporting private and public companies, Abingworth aims to partner with the most innovative entrepreneurs to address significant unmet needs in healthcare.

 

Employee Rating

0More
TypeInvestor
HQLondon, GB
Founded1973
Websiteabingworth.com
Abingworth was founded in 1973 and is headquartered in London, GB
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Abingworth

Tim Haines

Tim Haines

Managing Partner
Kurt von Emster

Kurt von Emster

Managing Partner
Stephen Bunting

Stephen Bunting

Chairman
James Abell

James Abell

Partner & CFO
Vincent Miles

Vincent Miles

Partner
Shelley Chu

Shelley Chu

Partner
Show more

Abingworth Office Locations

Abingworth has offices in Boston, Menlo Park and London
London, GB (HQ)
38 Jermyn St
Boston, US
501 420 Boylston St
Menlo Park, US
3000 Sand Hill Rd
Show all (3)
Report incorrect company information

Abingworth News and Updates

Abingworth Appoints Jackie Grant

LONDON, October 23, 2018 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, today announced that Jackie Grant, PhD, MBA, will join Abingworth as a Principal based in the company's Boston office. Jackie has more than 10 years of scientific, research...

Abingworth Appoints Brian Gallagher, Jr

LONDON, September 21, 2018 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, today announced that Brian Gallagher, PhD, will join Abingworth as a Partner based in the company's Boston office. Brian has more than 20 years of investing, business...

GammaDelta Therapeutics Appoints Michael Koslowski as CMO

LONDON, June 18, 2018 /PRNewswire/ -- GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies for cancer and other diseases announced today that it has strengthened its leadership team with the appointment of Michael Koslowski, MD, as Chief Medical...

NousCom wraps up Series B round

NousCom, a Swiss oncology company, has closed its Series B funding round at 42 million euros. Abingworth was the lead investor. Also, 5AM Ventures, LSP and Versant Ventures participated in the round.
Report incorrect company information

Abingworth Company Life and Culture

Report incorrect company information

Abingworth Frequently Asked Questions

  • When was Abingworth founded?

    Abingworth was founded in 1973.

  • Who are Abingworth key executives?

    Abingworth's key executives are Tim Haines, Kurt von Emster and Stephen Bunting.

  • What is Abingworth revenue?

    Latest Abingworth annual revenue is £9.8 m.

  • Who are Abingworth competitors?

    Competitors of Abingworth include Samsung NEXT, Third Prime Capital and Prestige Capital.

  • Where is Abingworth headquarters?

    Abingworth headquarters is located at 38 Jermyn St, London.

  • Where are Abingworth offices?

    Abingworth has offices in Boston, Menlo Park and London.

  • How many offices does Abingworth have?

    Abingworth has 3 offices.